DeepinderPSinghMD

Head & Neck, Thoracic Cancer

Assistant Professor, Radiation Oncology, University of Rochester School of Medicine & Dentistry

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
601 Elmwood Ave
Box 647
Rochester, NY 14642
Phone+1 585-275-5623

Fax+1 585-275-1531

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

2 citations
Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Kevin Bylund, Ellen Giampoli, Deepinder P. Singh, Timothy D. Doerr, Deepak M. Sahasrabudhe
Cancer Investigation. 2008-07-01
171 citations
Is there a favorable subset of patients with prostate cancer who develop oligometastases
Deepinder P. Singh, Won Sam Yi, R.A. Brasacchio, A. Muhs, T. Smudzin
International Journal of Radiation Oncology, Biology, Physics. 2004-01-01
31 citations
Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
Haoming Qiu, Alan W. Katz, Amit K. Chowdhry, Kenneth Y. Usuki, Deepinder P. Singh
American Journal of Clinical Oncology. 2015-08-11

Journal Articles

Comparison of Single- and Five-Fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early Stage Non-Small Cell Lung Cancer: A Two-Institution Propen...
Yusef Syed, Harish K Malhotra, Yuhchyau Chen, Deepinder P Singh, Anurag K Singh, Clinical Lung Cancer

Comparison of Single- and Five-Fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early Stage Non-Small Cell Lung Cancer: A Two-Institution Propensity Matched AnalysisJuly 2018